Loading provider…
Loading provider…
Neurology Physician in Chicago, IL
NPI: 1003899428Primary Practice Location
JACKSON PARK HOSPITAL
7531 S Stony Island Ave, Chicago, IL
Primary Employer
Southeast Chicago Neurology Associates SC
jacksonparkhospital.org
HQ Phone
Get MD Anil's Phone Numberphone_androidMobile
Get MD Anil's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
IL State Medical License
1989 - 2026

American Board of Psychiatry and Neurology
Neurology
American Board of Clinical Pharmacology
Diplomate • 1992 - 1992
1992 - 1992
King George's Medical College
M.D. • 1979 - 1982
1979 - 1982
M.D. • 1979 - 1982
1979 - 1982
King George's/CSM Medical College
Medical School
Until 1977
University of Illinois College of Medicine - Chicago
medicine.uic.edu
1987 - 1988
1987 - 1988
Post-Doctoral Fellowship • 1987 - 1988
1987 - 1988
Erasmus University Rotterdam
Ph.D. • 1992 - 1996
1992 - 1996
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 155 | 421 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 140 | 153 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 99 | 337 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 88 | 164 |
| 5 | 95819Measurement and recording of brain wave (EEG) activity, awake and asleep | 73 | 73 |
Centhaquin antinociception in mice is mediated by α2A- and α2B- but not α2C-adrenoceptors.
Authors: Shaifali Bhalla, Izna Ali, Anil Gulati
Publication Date: 2013-09
A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin®) as a Resuscitative Agent in Hypovolemic Shock Patients.
Authors: Sohrab Naushad Ali
Publication Date: 2021-05-25
Emission of volatile organic compounds from medical equipment inside neonatal incubators.
Lead Sponsor: Pharmazz, Inc.
Intervention / Treatment: DRUG: PMZ-1620 (sovateltide) along with standard treatment, DRUG: Normal Saline along with standard treatment
Lead Sponsor: Pharmazz, Inc.
Intervention / Treatment: DRUG: Centhaquine + Standard Treatment, DRUG: Normal saline + Standard Treatment
Lead Sponsor: Pharmazz, Inc.
Intervention / Treatment: DRUG: PMZ-1620 along with standard treatment, DRUG: Normal Saline along with standard treatment